Blogs about: Incyte
Featured Blog
Incytes JAK2 inhibitor INCB18424 demonstrates POC in Psoriasis
Incyte have reported positive results from Phase IIa clinical trials of JAK2 inhibitor INCB18424 in patients with mild to moderate psoriasis.… more →
Kinase News
Monday Biotech Deal Review: December 21, 2009
Jeremy G wrote 5 days ago: This week’s deal review shows no signs of a holiday showdown. In Canada, BioMS’ deal wi … more →
Tiffany, J. Crew, TiVo, Incyte are big movers (AP)
marketsnewss wrote 3 weeks ago: NEW YORK (AP) — The following stocks were among those that moved substantially or traded heavi … more →
Novartis and Incyte enter licensing agreement for blood disorders and cancer drugs
silico wrote 1 month ago: On November 25 2009 Novartis entered a licensing agreement with Incyte Corporation for exclusive rig … more →
Incyte Provides Update On Special Protocol Assessment For INCB18424 As A New Treatment For Myelofibrosis
healtherm2 wrote 6 months ago: Incyte Corporation (Nasdaq:INCY) announced that based on recent input from the U.S. Food and Drug Ad … more →
Bridging the Gap- My passion for ministry AND church
— 2 comments
clarkwithers wrote 9 months ago: So over the past few months I have had a passion stirring inside of me. Though I haven’t spoke … more →
Incytes JAK2 inhibitor INCB18424 demonstrates POC in Psoriasis
crimsoncanary wrote 1 year ago: Incyte have reported positive results from Phase IIa clinical trials of JAK2 inhibitor INCB18424 in … more →
3p.m.
clarkwithers wrote 1 year ago: So I’m sitting here at 3 in the afternoon, it’s about 200˚ in my car and I’m done … more →
Incyte report on INCB18424 and INCB28050 progress
crimsoncanary wrote 1 year ago: In 2nd quarter results Incyte have provided an update on JAK2 inhibitors INC18424 and INCB28050 … more →
Complacency...
clarkwithers wrote 1 year ago: Have you ever become complacent in life? Has life ever just seemed to slip by with no real passion, … more →
Incytes INCB-18424 shows efficacy in RA
crimsoncanary wrote 1 year ago: Phase I data presented at EULAR show Incytes JAK 1/2 inhibitor INCB018424 to demonstrate efficacy in … more →
Incyte's JAK inhibitor INCB18424 shows efficacy in treating Myelofibrosis symptoms
crimsoncanary wrote 1 year ago: Phase I/II data presented at ASCO show Incyte’s JAK inhibitor INCB18424 reduced fatigue, night … more →
Just an intro...again...
clarkwithers wrote 1 year ago: So anyway… starting a new blog…I’ve been playing around with blogspot and wordpres … more →
Incyte highlight progress of INCB18424, JAK Inhibitor
crimsoncanary wrote 1 year ago: Incyte updates with progress of JAK inhibitor INCB18424 during first quarter conference call: Myelof … more →
